Inflation-adjusted CEO pay in nonprofit hospitals climbed between 2012 and 2019, with higher compensation associated with larger size and profits, according to a new study from Houston-based Rice University’s Baker Institute for Public Policy.
The study, published Aug. 12 in Medical Care, analyzed more than 1,800 health systems and independent hospitals using IRS 990 and Schedule H tax filings to identify CEOs and their total compensation.
Key findings from the study include:
1. CEO average pay climbed 34% between 2012 and 2019, rising from about $1 million to $1.3 million. By comparison, registered nurses’ average salaries grew 2.3% during the same period.
2. Compensation was strongly tied to hospital size and profits. In 2019, CEOs of organizations with at least 500 beds earned 157% more than those leading hospitals with fewer than 100 beds.
3. Pay was modestly linked to lower mortality and readmission rates, but these quality-related associations weakened over time, the researchers said.
Read the full study here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
